CUREGENIX CORP has a total of 16 patent applications. Its first patent ever was published in 2016. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ISOFOL MEDICAL AB, PEPTINOVO BIOPHARMA LLC and ATOSSA GENETICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Republic of Korea | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Measuring microorganism processes | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | An Songzhu | 16 |
#2 | Huang Tao | 16 |
#3 | Qin Xiaoli | 16 |
Publication | Filing date | Title |
---|---|---|
WO2016191525A1 | Tumor biomarkers and use thereof | |
CN107613980A | combination composition for immunotherapy |